These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 33340584)

  • 21. ABCB4 disease: Many faces of one gene deficiency.
    Sticova E; Jirsa M
    Ann Hepatol; 2020; 19(2):126-133. PubMed ID: 31759867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and genetic characterization of pediatric patients with progressive familial intrahepatic cholestasis type 3 (PFIC3): identification of 14 novel ABCB4 variants and review of the literatures.
    Chen R; Yang FX; Tan YF; Deng M; Li H; Xu Y; Ouyang WX; Song YZ
    Orphanet J Rare Dis; 2022 Dec; 17(1):445. PubMed ID: 36550572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury.
    Moustafa T; Fickert P; Magnes C; Guelly C; Thueringer A; Frank S; Kratky D; Sattler W; Reicher H; Sinner F; Gumhold J; Silbert D; Fauler G; Höfler G; Lass A; Zechner R; Trauner M
    Gastroenterology; 2012 Jan; 142(1):140-151.e12. PubMed ID: 22001865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization and structural implications of 25 new ABCB4 mutations in progressive familial intrahepatic cholestasis type 3 (PFIC3).
    Degiorgio D; Colombo C; Seia M; Porcaro L; Costantino L; Zazzeron L; Bordo D; Coviello DA
    Eur J Hum Genet; 2007 Dec; 15(12):1230-8. PubMed ID: 17726488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional characterization of ABCB4 mutations found in progressive familial intrahepatic cholestasis type 3.
    Park HJ; Kim TH; Kim SW; Noh SH; Cho KJ; Choi C; Kwon EY; Choi YJ; Gee HY; Choi JH
    Sci Rep; 2016 Jun; 6():26872. PubMed ID: 27256251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic variability in Tunisian PFIC3 patients harboring a complex genotype with a differential clinical outcome of UDCA treatment.
    Khabou B; Mahjoub B; Barbu V; Balhoudi N; Wardani A; Sfar MT; Fakhfakh F
    Clin Chim Acta; 2018 Nov; 486():122-128. PubMed ID: 30036524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First description of ABCB4 gene deletions in familial low phospholipid-associated cholelithiasis and oral contraceptives-induced cholestasis.
    Pasmant E; Goussard P; Baranes L; Laurendeau I; Quentin S; Ponsot P; Consigny Y; Farges O; Condat B; Vidaud D; Vidaud M; Chen JM; Parfait B
    Eur J Hum Genet; 2012 Mar; 20(3):277-82. PubMed ID: 21989363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ATP8B1, ABCB11, and ABCB4 Genes Defects: Novel Mutations Associated with Cholestasis with Different Phenotypes and Outcomes.
    Al-Hussaini A; Lone K; Bashir MS; Alrashidi S; Fagih M; Alanazi A; AlYaseen S; Almayouf A; Alruwaithi M; Asery A
    J Pediatr; 2021 Sep; 236():113-123.e2. PubMed ID: 33915153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.
    Davit-Spraul A; Gonzales E; Baussan C; Jacquemin E
    Semin Liver Dis; 2010 May; 30(2):134-46. PubMed ID: 20422496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ABCB4 disease mimicking morbus Wilson: A potential diagnostic pitfall.
    Sticova E; Neroldova M; Kotalova R; Subhanova I; Jirsa M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):121-125. PubMed ID: 31728073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In silico investigation of the impact of synonymous variants in ABCB4 gene on mRNA stability/structure, splicing accuracy and codon usage: Potential contribution to PFIC3 disease.
    Khabou B; Siala-Sahnoun O; Gargouri L; Mkaouar-Rebai E; Keskes L; Hachicha M; Fakhfakh F
    Comput Biol Chem; 2016 Dec; 65():103-109. PubMed ID: 27788395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in
    Wang R; Sheps JA; Liu L; Han J; Chen PSK; Lamontagne J; Wilson PD; Welch I; Borchers CH; Ling V
    J Lipid Res; 2019 Jan; 60(1):85-97. PubMed ID: 30416103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic cytochrome P450 deficiency in mouse models for intrahepatic cholestasis predispose to bile salt-induced cholestasis.
    Kunne C; de Graaff M; Duijst S; de Waart DR; Oude Elferink RP; Paulusma CC
    Lab Invest; 2014 Oct; 94(10):1103-13. PubMed ID: 25068656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary lecithin protects against cholestatic liver disease in cholic acid-fed Abcb4- deficient mice.
    Lamireau T; Bouchard G; Yousef IM; Clouzeau-Girard H; Rosenbaum J; Desmoulière A; Tuchweber B
    Pediatr Res; 2007 Feb; 61(2):185-90. PubMed ID: 17237720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical phenotype and genotype analysis of progressive familial intrahepatic cholestasis type 3 caused by novel ABCB4 gene mutation].
    Ye XL; Yu FH; Zhou J; Zhao CN; Wu J
    Zhonghua Er Ke Za Zhi; 2024 Jul; 62(7):649-654. PubMed ID: 38955683
    [No Abstract]   [Full Text] [Related]  

  • 36. A novel etiologic factor of highly elevated cholestanol levels: progressive familial intrahepatic cholestasis.
    Küçükçongar Yavaş A; Çavdarlı B; Ünal Uzun Ö; Uncuoğlu A; Gündüz M
    J Pediatr Endocrinol Metab; 2020 May; 33(5):665-669. PubMed ID: 32229667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ivacaftor-Mediated Potentiation of ABCB4 Missense Mutations Affecting Critical Motifs of the NBDs: Repositioning Perspectives for Hepatobiliary Diseases.
    Delaunay JL; Elbahnsi A; Bruneau A; Madry C; Durand-Schneider AM; Stary A; Housset C; Gautheron J; Callebaut I; Aït-Slimane T
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case series of progressive familial intrahepatic cholestasis type 3: Characterization of variants in
    Cheng J; Gong L; Mi X; Wu X; Zheng J; Yang W
    Front Med (Lausanne); 2022; 9():962408. PubMed ID: 36569137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of clinical characteristic of children with progressive familial intrahepatic cholestasis type 3].
    Cao LL; Yan JG; Feng DN; Dong Y; Xu ZQ; Wang FC; Gao YJ; Zhu SS; Zhang M
    Zhonghua Er Ke Za Zhi; 2024 May; 62(5):462-466. PubMed ID: 38623015
    [No Abstract]   [Full Text] [Related]  

  • 40. Novel mutation in a Chinese patient with progressive familial intrahepatic cholestasis type 3.
    Sun HZ; Shi H; Zhang SC; Shen XZ
    World J Gastroenterol; 2015 Jan; 21(2):699-703. PubMed ID: 25593501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.